-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Post-antibiotic era is a worldwide challenge for health care: what to do ?
Asad U Khan
Letter to Editor: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Ophthalmic pharmaceutical clinical trials: design considerations
Paul Varner
Clinical Trail Perspective: Clinical Investigation
-
Clinical trial using a drug form of IL-2 hopes to improve management of Type 1 diabetes
News and Views: Clinical Investigation
-
Clinical trial using a drug form of IL-2 hopes to improve management of Type 1 diabetes
News and Views: Clinical Investigation
-
Clinical trial using a drug form of IL-2 hopes to improve management of Type 1 diabetes
News and Views: Clinical Investigation
-
Clinical trial using a drug form of IL-2 hopes to improve management of Type 1 diabetes
News and Views: Clinical Investigation
-
Clinical trial using a drug form of IL-2 hopes to improve management of Type 1 diabetes
News and Views: Clinical Investigation
-
Clinical trial using a drug form of IL-2 hopes to improve management of Type 1 diabetes
News and Views: Clinical Investigation
-
Clinical trial using a drug form of IL-2 hopes to improve management of Type 1 diabetes
News and Views: Clinical Investigation
-
Clinical trial using a drug form of IL-2 hopes to improve management of Type 1 diabetes
News and Views: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Clinical innovation for neurodegenerative diseases
Olivier Blin, Ceri H Davies, Bai Lu
Editorial: Clinical Investigation
-
Results and implications of the Trastuzumab for Gastric Cancer (ToGA) trial
Dok Hyun Yoon1 & Yoon-Koo Kang
Review Article: Clinical Investigation
-
Results and implications of the Trastuzumab for Gastric Cancer (ToGA) trial
Dok Hyun Yoon1 & Yoon-Koo Kang
Review Article: Clinical Investigation
-
Results and implications of the Trastuzumab for Gastric Cancer (ToGA) trial
Dok Hyun Yoon1 & Yoon-Koo Kang
Review Article: Clinical Investigation
-
Results and implications of the Trastuzumab for Gastric Cancer (ToGA) trial
Dok Hyun Yoon1 & Yoon-Koo Kang
Review Article: Clinical Investigation
-
Results and implications of the Trastuzumab for Gastric Cancer (ToGA) trial
Dok Hyun Yoon1 & Yoon-Koo Kang
Review Article: Clinical Investigation
-
Results and implications of the Trastuzumab for Gastric Cancer (ToGA) trial
Dok Hyun Yoon1 & Yoon-Koo Kang
Review Article: Clinical Investigation
-
Results and implications of the Trastuzumab for Gastric Cancer (ToGA) trial
Dok Hyun Yoon1 & Yoon-Koo Kang
Review Article: Clinical Investigation
-
Results and implications of the Trastuzumab for Gastric Cancer (ToGA) trial
Dok Hyun Yoon1 & Yoon-Koo Kang
Review Article: Clinical Investigation